Related by context. Frequent words. (Click for all words.) 65 breast colorectal 65 bladder cancers 64 breast colon 63 lung prostate 62 colorectal cancer CRC 62 prostate breast 61 gastrointestinal cancers 61 colon breast 60 prostate lung 60 cancers 60 breast cervical 59 lung colon 59 breast ovarian 59 non squamous 58 colon lung 58 colorectal cancers 58 prostate cancers 58 pancreatic cancers 57 colorectal cancer 57 lung ovarian 57 gastric cancers 57 uterine cancers 57 medullary thyroid cancer 57 squamous cell 56 squamous 56 neuroendocrine tumors 56 lung cancers 56 breast prostate 56 colorectal 56 malignancies 56 bone metastasis 55 gynecological cancers 55 gynecologic cancers 55 squamous cell carcinomas 55 hormonal therapies 55 prostate specific 54 nasopharyngeal cancer 54 metastatic colon cancer 54 hematologic cancers 54 colon cancers 54 HER2 positive metastatic breast 54 Avastin bevacizumab 54 androgen independent 54 axitinib 54 ovarian cancers 54 Jevtana 53 soft tissue sarcomas 53 gastrointestinal stromal tumors 53 cervical dysplasia 53 pleural mesothelioma 53 recurrent ovarian cancer 53 BRCA2 mutations 53 H. pylori infection 53 cutaneous T cell 53 CMV disease 53 Taxotere ® 53 adenocarcinomas 53 lymphomas 53 rectal cancer 53 darapladib 53 pre cancerous polyps 53 temsirolimus 53 colon tumors 52 Torisel 52 HER2 positive breast cancer 52 lung cancer 52 refractory multiple myeloma 52 thyroid cancers 52 hepatocellular carcinoma 52 colorectal tumors 52 colorectal polyps 52 myelodysplastic syndrome MDS 52 HER2 positive 52 Malignant gliomas 52 precancerous growths 52 melanoma 52 neoadjuvant therapy 52 pre cancerous lesions 52 hepatocellular carcinoma HCC 51 prophylactic vaccines 51 sarcomas 51 epithelial ovarian cancer 51 anticancer therapy 51 colon cancer 51 HRPC 51 hematologic malignancies 51 cervical cancers 51 estrogen receptor negative 51 Human Papilloma Virus HPV 51 leukemias 51 follicular non 51 patients undergoing chemotherapy 51 metastatic renal cell carcinoma 51 benign breast 51 TREANDA 51 Non Hodgkin lymphoma 51 carcinomas 51 Nimotuzumab 51 malignant lesions 50 hepatitis C HCV 50 NSCLC